HHL:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 8.58

Change

-0.06 (-0.69)%

Market Cap

N/A

Volume

0.15M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.37 (-0.92%)

CAD 2.91B
ZWU:CA BMO Covered Call Utilities ETF

-0.14 (-1.21%)

CAD 1.92B
TXF:CA First Asset Tech Giants Covere..

-0.19 (-0.87%)

CAD 0.65B
XIT:CA iShares S&P/TSX Capped Informa..

-0.54 (-0.92%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

-0.18 (-0.24%)

CAD 0.64B
HTA:CA Harvest Tech Achievers Growth ..

-0.16 (-0.85%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.33 (-1.47%)

CAD 0.45B
CWW:CA iShares Global Water Common Cl..

-0.12 (-0.20%)

CAD 0.34B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.47 (-1.67%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+0.04 (+0.06%)

CAD 0.29B

ETFs Containing HHL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.85% 37% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.85% 37% F 38% F
Trailing 12 Months  
Capital Gain 10.57% 29% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.57% 29% F 35% F
Trailing 5 Years  
Capital Gain 17.86% 29% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.86% 29% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike